{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:05:50Z","timestamp":1785769550608,"version":"3.56.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"51","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12,19]]},"abstract":"<jats:p>\n                    The role of gut microbiota and their metabolites in respiratory diseases via the \u201cgut-lung axis\u201d has garnered increasing attention, yet their specific mechanisms in bronchiectasis (BIS) remain unclear. This study integrates network pharmacology with bioinformatics approaches, including Mendelian randomization (MR) and molecular dynamics (MD), to systematically investigate the mechanisms of gut microbiota metabolites in BIS pathogenesis and explore potential therapeutic interventions. Intersection targets between gut microbiota metabolites and BIS were screened using network pharmacology. A protein\u2013protein interaction (PPI) network was constructed, and MR combined with MD simulations were employed to validate interactions between core targets and metabolites. A total of 40 metabolite-disease intersection targets were identified, with 17 core genes prioritized. MR analysis revealed a significant protective effect of the peroxisome proliferator-activated receptor gamma (PPARG) gene against BIS (IVW method: \u03b2\u2005=\u2005\u22120.141, OR\u2005=\u20050.868,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.030). Molecular docking confirmed strong binding affinity of butyrate and 10-keto-12Z-octadecenoic acid to PPARG (affinity: \u22123.731 and \u22125.666 kcal\/mol, respectively). Drug-likeness and toxicological analyses indicated both compounds possess therapeutic potential, with 10-keto-12Z-octadecenoic acid demonstrating superior properties. MD simulations further validated the stability of metabolite-PPARG complexes. Gut microbiota metabolites mediate protective mechanisms in BIS pathogenesis through PPARG, and 10-keto-12Z-octadecenoic acid emerges as a novel lead compound for treatment. This study provides a theoretical foundation for precision therapy targeting the gut-lung axis.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000046535","type":"journal-article","created":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T04:00:58Z","timestamp":1766203258000},"page":"e46535","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Deciphering the role of gut microbiota metabolites in bronchiectasis through the perspectives of network pharmacology, Mendelian randomization, and molecular dynamics"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8868-6777","authenticated-orcid":false,"given":"Qinzhe","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Province, China"},{"name":"Department of Pulmonary and Critical Care Medicine, The Affiliated Minzu Hospital of Guangxi Medical University, Nanning, Guangxi Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaochu","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinling","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haizhu","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaopu","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4065-7886","authenticated-orcid":false,"given":"Jinliang","family":"Kong","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260522","doi-asserted-by":"crossref","first-page":"240055","DOI":"10.1183\/16000617.0055-2024","article-title":"Pathophysiology and genomics of bronchiectasis.","volume":"33","author":"Perea","year":"2024","journal-title":"Eur Respir Rev"},{"key":"R2-20260522","doi-asserted-by":"crossref","first-page":"1405399","DOI":"10.3389\/fcimb.2024.1405399","article-title":"Lung microbiome: new insights into bronchiectasis\u2019 outcome.","volume":"14","author":"Azoicai","year":"2024","journal-title":"Front Cell Infect Microbiol"},{"key":"R3-20260522","doi-asserted-by":"crossref","first-page":"2400518","DOI":"10.1183\/13993003.00518-2024","article-title":"Bronchiectasis management in adults: state of the art and future directions.","volume":"63","author":"Choi","year":"2024","journal-title":"Eur Respir J"},{"key":"R4-20260522","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1186\/s12931-022-02229-w","article-title":"Altered fecal microbiome and metabolome in adult patients with non-cystic fibrosis bronchiectasis.","volume":"23","author":"Wang","year":"2022","journal-title":"Respir Res"},{"key":"R5-20260522","doi-asserted-by":"crossref","first-page":"1521214","DOI":"10.3389\/fnut.2024.1521214","article-title":"Therapeutic role of gut microbiota in lung injury-related cognitive impairment.","volume":"11","author":"Cheng","year":"2024","journal-title":"Front Nutr"},{"key":"R6-20260522","doi-asserted-by":"crossref","first-page":"eadq4409","DOI":"10.1126\/scitranslmed.adq4409","article-title":"A gut Eggerthella lenta-derived metabolite impairs neutrophil function to aggravate bacterial lung infection.","volume":"17","author":"Wang","year":"2025","journal-title":"Sci Transl Med"},{"key":"R7-20260522","doi-asserted-by":"crossref","first-page":"954339","DOI":"10.3389\/fimmu.2022.954339","article-title":"Possible role of gut microbes and host\u2019s immune response in gut-lung homeostasis.","volume":"13","author":"Rastogi","year":"2022","journal-title":"Front Immunol"},{"key":"R8-20260522","doi-asserted-by":"crossref","first-page":"240179","DOI":"10.1183\/16000617.0179-2024","article-title":"Neutrophilic inflammation in bronchiectasis.","volume":"34","author":"Chalmers","year":"2025","journal-title":"Eur Respir Rev"},{"key":"R9-20260522","doi-asserted-by":"crossref","first-page":"9458","DOI":"10.3390\/ijms25179458","article-title":"Mitochondrial plasticity and glucose metabolic alterations in human cancer under oxidative stress-from viewpoints of chronic inflammation and neutrophil extracellular traps (NETs).","volume":"25","author":"Lee","year":"2024","journal-title":"Int J Mol Sci"},{"key":"R10-20260522","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.3390\/ijms24055034","article-title":"Neutrophil extracellular traps in airway diseases: pathological roles and therapeutic implications.","volume":"24","author":"Jo","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R11-20260522","doi-asserted-by":"crossref","first-page":"2401050","DOI":"10.1183\/13993003.01050-2024","article-title":"Targeting neutrophil serine proteases in bronchiectasis.","volume":"65","author":"Chalmers","year":"2025","journal-title":"Eur Respir J"},{"key":"R12-20260522","doi-asserted-by":"crossref","first-page":"109293","DOI":"10.1016\/j.clim.2023.109293","article-title":"PPARgamma inhibits small airway remodeling through mediating the polarization homeostasis of alveolar macrophages in COPD.","volume":"250","author":"He","year":"2023","journal-title":"Clin Immunol"},{"key":"R13-20260522","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/cei\/uxab036","article-title":"The PPAR-gamma agonist pioglitazone exerts proinflammatory effects in bronchial epithelial cells during acute Pseudomonas aeruginosa pneumonia.","volume":"207","author":"Ferreira","year":"2022","journal-title":"Clin Exp Immunol"},{"key":"R14-20260522","doi-asserted-by":"crossref","first-page":"e41628","DOI":"10.1016\/j.heliyon.2025.e41628","article-title":"PPARG\/SPP1\/CD44 signaling pathway in alveolar macrophages: mechanisms of lipid dysregulation and therapeutic targets in idiopathic pulmonary fibrosis.","volume":"11","author":"Li","year":"2025","journal-title":"Heliyon"},{"key":"R15-20260522","doi-asserted-by":"crossref","first-page":"e0202296","DOI":"10.1371\/journal.pone.0202296","article-title":"PPAR\u03b3 is reduced in the airways of non-CF bronchiectasis subjects and is inversely correlated with the presence of Pseudomonas aeruginosa.","volume":"13","author":"Burr","year":"2018","journal-title":"PLoS One"},{"key":"R16-20260522","doi-asserted-by":"crossref","first-page":"e0198723","DOI":"10.1128\/mbio.01987-23","article-title":"Butyrate protects against MRSA pneumonia via regulating gut-lung microbiota and alveolar macrophage M2 polarization.","volume":"14","author":"Zhao","year":"2023","journal-title":"mBio"},{"key":"R17-20260522","doi-asserted-by":"crossref","first-page":"1347676","DOI":"10.3389\/fimmu.2024.1347676","article-title":"Faecalibacterium duncaniae as a novel next generation probiotic against influenza.","volume":"15","author":"Chollet","year":"2024","journal-title":"Front Immunol"},{"key":"R18-20260522","doi-asserted-by":"crossref","first-page":"14191","DOI":"10.3390\/ijms241814191","article-title":"Butyrate protects against SARS-CoV-2-induced tissue damage in golden hamsters.","volume":"24","author":"Yu","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R19-20260522","doi-asserted-by":"crossref","first-page":"1292266","DOI":"10.3389\/fmicb.2023.1292266","article-title":"Lactiplantibacillusplantarum APsulloc331261 (GTB1()) promotes butyrate production to suppress mucin hypersecretion in a murine allergic airway inflammation model.","volume":"14","author":"Kim","year":"2023","journal-title":"Front Microbiol"},{"key":"R20-20260522","doi-asserted-by":"crossref","first-page":"1011732","DOI":"10.3389\/fnut.2022.1011732","article-title":"Butyrate: connecting the gut-lung axis to the management of pulmonary disorders.","volume":"9","author":"Correa","year":"2022","journal-title":"Front Nutr"},{"key":"R21-20260522","doi-asserted-by":"crossref","first-page":"e2300515","DOI":"10.1002\/adhm.202300515","article-title":"Mannose-decorated co-polymer facilitates controlled release of butyrate to accelerate chronic wound healing.","volume":"12","author":"Lauterbach","year":"2023","journal-title":"Adv Healthc Mater"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000046535","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T14:15:53Z","timestamp":1785766553000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000046535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,19]]},"references-count":21,"journal-issue":{"issue":"51","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000046535","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,19]]},"assertion":[{"value":"2025-05-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-26","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}